Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HLN | US
0.05
0.52%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
24/04/2026
9.58
9.60
9.65
9.57
Haleon plc together with its subsidiaries engages in the research development manufacture and sale of various consumer healthcare products in North America Europe the Middle East Africa Latin America and the Asia Pacific. The company provides oral health pain relief respiratory health digestive health and other products as well as vitamins minerals and supplements. Its portfolio of brands includes Advil Sensodyne Panadol Voltaren Theraflu Otrivin Polident parodontax and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge the United Kingdom.
View LessLow 6-Month Volatility (<30%)
Largecap (10B - 200B USD)
Low Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Price Below SMA10D
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
19.0%1 month
16.0%3 months
24.8%6 months
22.9%32.55
19.68
2.12
0.53
0.27
18.14
3.81
1.50
2.60B
43.32B
43.32B
1.56
23.14
3.20
0.80
6.82
3.60
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.60
Range1M
0.78
Range3M
1.93
Rel. volume
0.75
Price X volume
49.90M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| argenx SE | ARGX | Biotechnology | 780.25 | 46.66B | -0.98% | n/a | 0.80% |
| Alnylam Pharmaceuticals Inc | ALNY | Biotechnology | 305.54 | 39.23B | -2.63% | n/a | -88302.54% |
| Teva Pharmaceutical Industries Limited | TEVA | Drug Manufacturers-Specialty & Generic | 30.64 | 34.71B | -1.83% | n/a | 297.56% |
| Axovant Sciences Ltd | AXON | Biotechnology | 397.12 | 30.01B | 1.14% | 114.97 | 37.35% |
| Repros Therapeutics Inc | RPRX | Biotechnology | 49.38 | 29.31B | -0.52% | 18.65 | 117.38% |
| Biogen Inc | BIIB | Biotechnology | 184.38 | 26.86B | -1.86% | 23.98 | 43.13% |
| United Therapeutics Corporation | UTHR | Biotechnology | 567.16 | 25.23B | -0.99% | 16.92 | 8.78% |
| Insmed Incorporated | INSM | Biotechnology | 135.17 | 23.23B | -6.02% | n/a | 3553.44% |
| REVOLUTION MEDICINES INC. | RVMD | Biotechnology | 135.3 | 22.60B | 0.61% | n/a | 5.40% |
| Roivant Sciences Ltd. Common Shares | ROIV | Biotechnology | 27.41 | 20.27B | -2.59% | 2.08 | 6.97% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| PPL Corporation | PPL | Building Products & Equipment | 38.75 | 28.59B | 0.54% | 28.90 | 114.80% |
| Avery Dennison Corporation | AVY | Building Products & Equipment | 165.5 | 13.33B | -1.15% | 27.93 | 140.74% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| HNI Corporation | HNI | Building Products & Equipment | 37.7 | 1.78B | 1.32% | 22.12 | 76.47% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 18.14 | 24.85 | Cheaper |
| Ent. to Revenue | 3.81 | 361.91 | Cheaper |
| PE Ratio | 32.55 | 30.05 | Par |
| Price to Book | 2.12 | 13.15 | Cheaper |
| Dividend Yield | 1.56 | 2.94 | Poor |
| Std. Deviation (3M) | 24.83 | 65.24 | Lower Risk |
| Debt to Equity | 0.53 | -1.88 | Expensive |
| Debt to Assets | 0.27 | 0.48 | Cheaper |
| Market Cap | 43.32B | 3.71B | Market Leader |